Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Major liver resection for hepatocellular carcinoma in the morbidly obese: A proposed strategy to improve outcome | BioMed Central World Journal of Surgical Oncology Open Access Technical innovations Major liver resection for hepatocellular carcinoma in the morbidly obese A proposed strategy to improve outcome Omar Barakat 1 Mark D Skolkin2 Barry D Toombs2 John H Fischer II2 Claire F Ozaki1 and R Patrick Wood1 Address Department of Surgery the Texas Heart Institute at St. Luke s Episcopal Hospital Houston Texas USA and 2Department of Interventional Radiology The Texas Heart Institute at St. Luke s Episcopal Hospital Houston Texas USA Email Omar Barakat - omarbarakat@ Mark D Skolkin - mskolkin@ Barry D Toombs - btoombs@ John H Fischer - jfischer@ Claire F Ozaki - c0z@ R Patrick Wood - rpwood7070@ Corresponding author Published 10 September 2008 Received 20 May 2008 World Journal of Surgical Oncology 2008 6 100 doi l477-78l9-6-l00 Accepted 10 September 2008 This article is available from http content 6 l l00 2008 Barakat et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Morbid obesity strongly predicts morbidity and mortality in surgical patients. However obesity s impact on outcome after major liver resection is unknown. Case presentation We describe the management of a large hepatocellular carcinoma in a morbidly obese patient body mass index 50 kg m2 . Additionally we propose a strategy for reducing postoperative complications and improving outcome after major liver resection. Conclusion To our knowledge this is the first report of major liver resection in a morbidly obese patient with hepatocellular carcinoma. The approach we used could make this operation nearly as safe in obese patients as it is in their normal-weight counterparts.
